New FDA regulations and widespread recalls - including an order to recall-and-destroy the Baxter COLLEAGUE - have evoked uncertainty in the smart pumps market.
For the new report, Smart Pumps 2011: The FDA Steps in - Provider Reactions to Market Turmoil, the Orem, Utah-based KLAS interviewed 116 providers about how recent FDA actions were affecting them specifically and the smart pump market as a whole. Every smart pump vendor has been involved in a recall at least once in the past 24 months. Nevertheless, providers are not staying out of the market. Only 9 percent of providers said these events will delay their current purchasing plans.
According to the report, few providers are leaving their smart pumps vendors because of recall issues. Even among Baxter COLLEAGUE customers, only about half indicated that the recall has harmed their overall opinion of Baxter.
Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.